China Medicine Cash Flow - Annual (OTCMKTS:CHME)

Add to My Stocks
$0.06 $0 (0%) CHME stock closing price Sep 19, 2018 (Closing)

The China Medicine cash flow statement helps investors understand how well the company is managing its cash flows. While its important to look at the China Medicine debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as China Medicine revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. The cash flow statement is essetial while conducting the China Medicine cash flow analysis and can be used to measure the operating performance of China Medicine compared to various industry peers like ACUR stock and GBIM stock. China Medicine had an inflow of $16.96M from operating activities, $-5.74M spend due to financing activities, and $-13.53M outflow due to investing activities for 2009.

View details of China Medicine cash flows for latest & last 10 financial years
show more
Fiscal year is Jan - Dec20092008
Net Income Cash Flow
1.71M9.12M
Depreciation Depletion Amortization Cash-Flow1.01M-
Net Increase (Decrease) in Assets Liabilities14.34M-5.35M
Cash From (used in) Discontinued Operations--
Other Adjustments Net-0.11M-
Net Cash from (used by) Operating Activities
16.96M4.2M
Increase (Decrease) in Prop Plant And Equipment-3.41M-2.66M
Acquisition Disposition of Subsidiaires-8M-
Increase (Decrease) in Investments--
Other Cash Inflow (Outflow) from Investment Activities-2.11M-5.19M
Net Cash from (used by) Investment Activities
-13.53M-7.86M
Issuance (Purchase) of Equity Shares--
Issuance (Repayment) of Debt Securities--
Increase (Decrease) in Bank & Other Borrowings-4.04M-
Payment of Dividends & Other Cash Distributions--
Other Cash from (used by) Financing Activities-1.75M-
Net Cash from (used by) Financing Activities
-5.74M-
Effect of Exchange Rate Changes on Cash--
Net Change in Cash & Cash Equivalents
-2.32M-2.97M
Cash & Equivalents at Beginning of Year2.79M5.76M
Cash & Equivalents at Year End-2.79M
All figures in USD. M: Millions of USD, B: Billions of USD.

China Medicine stock comparison chart provides an easy way to compare the stock price with peers along with details of China Medicine stock price history.
The statement of cash flows can be categorized into three main sections:

  • China Medicine saw a positive change in Net Change in Cash and Cash Equivalents of $-2.32M in 2009. Apart from the China Medicine stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • The cash generated from the core business or operations was a positive at $16.96M for China Medicine in the latest 2009. For an internet company, this would include all those activities which are involved in eventually selling advertisement space on its website or any online service.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $-13.53M for CHME in last 2009 report.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $-5.74M for China Medicine.

Key Financial Ratios For China Medicine Cash Flow

Annual Cash Flow Statements For China Medicine Corporation Peers

Acura Pharma cash flow, China Sky One Medical cash flow, GlobeImmune cash flow